Sodium Azide → 8-Methyl-6-(4-(trifluoromethoxy)phenyl)tetrazolo[1,5-a]pyridine

HRID 406429

반응식

HRID 406429 반응식
Cl[C:2]1[C:7]([CH3:8])=[CH:6][C:5]([C:9]2[CH:14]=[CH:13][C:12]([O:15][C:16]([F:19])([F:18])[F:17])=[CH:11][CH:10]=2)=[CH:4][N:3]=1.[N-:20]=[N+:21]=[N-:22].[Na+].CC1C=CC(S(O)(=O)=O)=CC=1.N1C=CC=CC=1>CN(C=O)C>[CH3:8][C:7]1[C:2]2[N:3]([N:20]=[N:21][N:22]=2)[CH:4]=[C:5]([C:9]2[CH:14]=[CH:13][C:12]([O:15][C:16]([F:19])([F:18])[F:17])=[CH:11][CH:10]=2)[CH:6]=1

참가 물질

5

실험 절차

A mixture of 2-chloro-3-methyl-5-(4-(trifluoromethoxy)phenyl)pyridine prepared as described above (58 mg, 0.20 mmol), sodium azide (21 mg, 0.30 mmol), and pyridine 4-methylbenzenesulfonate (5 mg, 0.02 mmol) in anhydrous DMF (2.0 mL) was capped in a Biotage microwave reaction vial and subjected to irradiation at 160° C. for 30 min. Cooled, pressure released by opening the cap, additional sodium azide (65 mg, 1.00 mmol) and pyridine 4-methylbenzenesulfonate (52 mg, 0.20 mmol) were added, capped, and subjected to irradiation at 200° C. for 30 min. After cooling, the mixture was concentrated in vacuo, diluted with DMF (1.0 mL) and MeOH (2.0 mL), filtered, and subjected to preparative HPLC with a gradient MeCN/H2O (5% to 98 containing 0.1% TFA to afford 8-methyl-6-(4-(trifluoromethoxy)phenyl)tetrazolo[1,5-a]pyridine

후처리

  1. customprepared
  2. customwas capped in a Biotage microwave reaction vial
  3. customsubjected to irradiation at 160° C. for 30 min
  4. temperatureCooled
  5. additionwere added
  6. customcapped
  7. customsubjected to irradiation at 200° C. for 30 min
  8. temperatureAfter cooling
  9. concentrationthe mixture was concentrated in vacuo
  10. additiondiluted with DMF (1.0 mL) and MeOH (2.0 mL)
  11. filtrationfiltered

출처 및 근거

ORD 기록
ord-b9e1e11282b14a3482377093d1a0040a
출처 데이터셋
uspto-grants-2014_06
특허 번호
US08754103B2

연결된 노트

불러오는 중…